Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis

被引：0
|
作者：
Bradley A. Warady
Eric Ng
Laura Bloss
May Mo
Franz Schaefer
Justine Bacchetta
机构：
[1] Children’s Mercy Kansas City,Division of Pediatric Nephrology
[2] Amgen Inc.,undefined
[3] Heidelberg University Hospital,undefined
[4] Department of Pediatric Nephrology,undefined
[5] Rheumatology and Dermatology,undefined
[6] Femme Mère Enfant Hospital,undefined
来源：
Pediatric Nephrology | 2020年 / 35卷
关键词：
Cinacalcet; CKD-MBD; Dialysis; Pediatric; sHPT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1679 / 1697
页数：18
相关论文
共 50 条
  • [31] Bridging/extrapolation between adult and pediatric subjects with CKD and SHPT receiving dialysis: a population PK and PK/PD analysis of Cinacalcet
    Chen, Ping
    Sohn, Winnie
    Narayanan, Adimoolam
    Gisleskog, Per Olsson
    Melhem, Murad
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S81 - S82
  • [32] Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
    Irene Ruderman
    Edward R. Smith
    Nigel D. Toussaint
    Tim D. Hewitson
    Stephen G. Holt
    BMC Nephrology, 19
  • [33] LONGITUDINAL CHANGES IN BONE AND MINERAL METABOLISM AFTER CESSATION OF CINACALCET IN DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Ruderman, I.
    Smith, E.
    Toussaint, N.
    Hewitson, T.
    Holt, S.
    NEPHROLOGY, 2018, 23 : 56 - 56
  • [34] Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism
    Ruderman, Irene
    Smith, Edward R.
    Toussaint, Nigel D.
    Hewitson, Tim D.
    Holt, Stephen G.
    BMC NEPHROLOGY, 2018, 19
  • [35] CHANGES IN BONE AND MINERAL METABOLISM MARKERS AFTER CESSATION OF CINACALCET IN DIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
    Ruderman, I.
    Holt, S.
    Hewitson, T.
    Smith, E.
    Krishnasamy, R.
    Gray, N.
    Hawley, C.
    Oliver, V.
    Talaulikar, G.
    Kirkland, G.
    Maslen, S.
    Toussaint, N.
    NEPHROLOGY, 2017, 22 : 39 - 39
  • [36] Effect of cinacalcet treatment on vascular arterial stiffness among peritoneal dialysis patients with secondary hyperparathyroidism
    Chow, Kai Ming
    Szeto, Cheuk Chun
    Kwan, Bonnie Ching-Ha
    Cheng, Phyllis Mei-Shan
    Pang, Wing Fai
    Leung, Chi Bon
    Li, Philip Kam-Tao
    NEPHROLOGY, 2014, 19 (06) : 339 - 344
  • [37] Cinacalcet HCl controls secondary hyperparathyroidism (HPT) in dialysis patients regardless of disease severity.
    Quarles, LD
    Zeig, S
    Spiegel, DM
    Silver, MR
    Vokes, TJ
    Torregrosa, JV
    Reichel, H
    Horl, WH
    Zani, V
    Klassen, PS
    Olson, KA
    Turner, SA
    Sprague, SM
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 463A - 463A
  • [38] Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism
    Yousaf, Farhanah
    Charytan, Chaim
    RENAL FAILURE, 2014, 36 (01) : 131 - 138
  • [39] Efficacy and safety of Cinacalcet on secondary hyperparathyroidism in Chinese chronic kidney disease patients receiving hemodialysis
    Mei, Changlin
    Chen, Nan
    Ding, Xiaoqiang
    Yu, Xueqing
    Wang, Li
    Qian, Jiaqi
    Wang, Mei
    Jiang, Gengru
    Li, Xuemei
    Hou, Fanfan
    Zuo, Li
    Wang, Niansong
    Liu, Hong
    HEMODIALYSIS INTERNATIONAL, 2016, 20 (04) : 589 - 600
  • [40] Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic-pharmacodynamic analysis of cinacalcet
    Chen, Ping
    Sohn, Winnie
    Narayanan, Adimoolam
    Gisleskog, Per Olsson
    Melhem, Murad
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (06) : 1312 - 1325
12345